Stephen T. Buckley

3.4k total citations
37 papers, 1.3k citations indexed

About

Stephen T. Buckley is a scholar working on Molecular Biology, Pharmaceutical Science and Oncology. According to data from OpenAlex, Stephen T. Buckley has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Pharmaceutical Science and 9 papers in Oncology. Recurrent topics in Stephen T. Buckley's work include Advanced Drug Delivery Systems (10 papers), Drug Transport and Resistance Mechanisms (8 papers) and Drug Solubulity and Delivery Systems (7 papers). Stephen T. Buckley is often cited by papers focused on Advanced Drug Delivery Systems (10 papers), Drug Transport and Resistance Mechanisms (8 papers) and Drug Solubulity and Delivery Systems (7 papers). Stephen T. Buckley collaborates with scholars based in Denmark, Ireland and Germany. Stephen T. Buckley's co-authors include Carsten Ehrhardt, Gert Fricker, Martin Brandl, Kerstin J. Frank, Sarah Fischer, Ulrik L. Rahbek, František Hubálek, Carlos Medina, Carlos Medina and Anthony M. Davies and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.

In The Last Decade

Stephen T. Buckley

37 papers receiving 1.2k citations

Peers

Stephen T. Buckley
Ping Meng China
Jason Zastre United States
Timo Korjamo Finland
Ping Meng China
Stephen T. Buckley
Citations per year, relative to Stephen T. Buckley Stephen T. Buckley (= 1×) peers Ping Meng

Countries citing papers authored by Stephen T. Buckley

Since Specialization
Citations

This map shows the geographic impact of Stephen T. Buckley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen T. Buckley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen T. Buckley more than expected).

Fields of papers citing papers by Stephen T. Buckley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen T. Buckley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen T. Buckley. The network helps show where Stephen T. Buckley may publish in the future.

Co-authorship network of co-authors of Stephen T. Buckley

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen T. Buckley. A scholar is included among the top collaborators of Stephen T. Buckley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen T. Buckley. Stephen T. Buckley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zosel, Franziska, Bhavesh Premdjee, A. G. Davies, et al.. (2025). To conjugate or not to conjugate? evaluating the potential use of cell-penetrating peptides for conjugation or complexation with oligonucleotides by surface plasmon resonance. International Journal of Pharmaceutics. 671. 125198–125198. 1 indexed citations
2.
Vazquez-Uribe, Ruben, et al.. (2025). Advanced microbiome therapeutics for oral delivery of peptides and proteins: Advances, challenges, and opportunities. Advanced Drug Delivery Reviews. 222. 115603–115603. 6 indexed citations
3.
Pinto, Soraia, Juliana Santos Rosa Viegas, Catarina Pacheco, et al.. (2024). Bioengineered Nanomedicines Targeting the Intestinal Fc Receptor Achieve the Improved Glucoregulatory Effect of Semaglutide in a Type 2 Diabetic Mice Model. ACS Nano. 18(41). 28406–28424. 9 indexed citations
4.
Buckley, Stephen T., Thomas Klitgaard, Niels Rode Kristensen, et al.. (2024). Pharmacokinetic Properties of a Once-Weekly Fixed-Ratio Combination of Insulin Icodec and Semaglutide Compared with Separate Administration of Each Component in Individuals with Type 2 Diabetes Mellitus. Clinical Drug Investigation. 44(11). 849–861. 4 indexed citations
5.
Pinto, Soraia, Stephen T. Buckley, Javad Garousi, et al.. (2024). Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular trafficking of semaglutide. Journal of Controlled Release. 366. 621–636. 26 indexed citations
6.
Puris, Elena, Andreas Brachner, Antje Appelt‐Menzel, et al.. (2023). Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line. Fluids and Barriers of the CNS. 20(1). 96–96. 9 indexed citations
7.
Rivera, Kristina R., et al.. (2023). Characterizing interspecies differences in gastric fluid properties to improve understanding of in vivo oral drug formulation performance. European Journal of Pharmaceutical Sciences. 183. 106386–106386. 4 indexed citations
8.
Loryan, Irena, Andreas Reichel, Bo Feng, et al.. (2022). Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—a Game Changing Parameter for CNS Drug Discovery and Development. Pharmaceutical Research. 39(7). 1321–1341. 62 indexed citations
9.
Fan, Weiwei, Aohua Wang, Yue Wu, et al.. (2019). Overcoming Poor Tabletability of Bulky Absorption Enhancers by Spray Drying Technology. Journal of Pharmaceutical Sciences. 108(6). 2128–2135. 3 indexed citations
10.
Kildegaard, Jonas, Stephen T. Buckley, Rasmus Hjorth Nielsen, et al.. (2019). Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide. Pharmaceutical Research. 36(3). 49–49. 63 indexed citations
11.
Buckley, Stephen T., František Hubálek, & Ulrik L. Rahbek. (2016). Chemically modified peptides and proteins - critical considerations for oral delivery. Tissue Barriers. 4(2). e1156805–e1156805. 31 indexed citations
12.
Buckley, Stephen T., Diego Álvarez de la Rosa, Brian J. Harvey, et al.. (2015). Expression and function of the epithelial sodium channel δ-subunit in human respiratory epithelial cells in vitro. Pflügers Archiv - European Journal of Physiology. 467(11). 2257–2273. 10 indexed citations
13.
Hubálek, František, et al.. (2014). The role of citric acid in oral peptide and protein formulations: Relationship between calcium chelation and proteolysis inhibition. European Journal of Pharmaceutics and Biopharmaceutics. 86(3). 544–551. 67 indexed citations
14.
Buckley, Stephen T., Kerstin J. Frank, Gert Fricker, & Martin Brandl. (2013). Biopharmaceutical classification of poorly soluble drugs with respect to “enabling formulations”. European Journal of Pharmaceutical Sciences. 50(1). 8–16. 186 indexed citations
15.
Zhou, Beiyun, Stephen T. Buckley, Vipul Patel, et al.. (2012). Troglitazone Attenuates TGF-β1-Induced EMT in Alveolar Epithelial Cells via a PPARγ-Independent Mechanism. PLoS ONE. 7(6). e38827–e38827. 30 indexed citations
16.
Buckley, Stephen T., Sarah Fischer, Gert Fricker, & Martin Brandl. (2011). In vitro models to evaluate the permeability of poorly soluble drug entities: Challenges and perspectives. European Journal of Pharmaceutical Sciences. 45(3). 235–250. 109 indexed citations
18.
Buckley, Stephen T., Carlos Medina, Anthony M. Davies, & Carsten Ehrhardt. (2011). Cytoskeletal re-arrangement in TGF-β1-induced alveolar epithelial-mesenchymal transition studied by atomic force microscopy and high-content analysis. Nanomedicine Nanotechnology Biology and Medicine. 8(3). 355–364. 37 indexed citations
19.
Ehrhardt, Carsten, Carlos Medina, Anthony M. Davies, & Stephen T. Buckley. (2011). Using Atomic Force Microscopy And High-Content Analysis For Investigations Into Cytoskeletal Re-Arrangement During TGF-Beta1-Induced Alveolar Epithelial-Mesenchymal Transition. A3501–A3501. 4 indexed citations
20.
Tewes, Frédéric, et al.. (2011). Investigations into the Fate of Inhaled Salmon Calcitonin at the Respiratory Epithelial Barrier. Pharmaceutical Research. 29(1). 332–341. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026